A citation-based method for searching scientific literature

Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann, Fakhera Ikram, Rene Schmidt, Sandra Ackermann, Anne Engesser, Yvonne Kahlert, Wenzel Vogel, Janine Altmüller, Peter Nürnberg, Jean Thierry-Mieg, Danielle Thierry-Mieg, Aruljothi Mariappan, Stefanie Heynck, Erika Mariotti, Kai-Oliver Henrich, Christian Gloeckner, Graziella Bosco, Ivo Leuschner, Michal R Schweiger, Larissa Savelyeva, Simon C Watkins, Chunxuan Shao, Emma Bell, Thomas Höfer, Viktor Achter, Ulrich Lang, Jessica Theissen, Ruth Volland, Maral Saadati, Angelika Eggert, Bram de Wilde, Frank Berthold, Zhiyu Peng, Chen Zhao, Leming Shi, Monika Ortmann, Reinhard Büttner, Sven Perner, Barbara Hero, Alexander Schramm, Johannes H Schulte, Carl Herrmann, Roderick J O'Sullivan, Frank Westermann, Roman K Thomas, Matthias Fischer. Nature 2015
Times Cited: 325







List of co-cited articles
1114 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The ALK(F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma.
Teeara Berry, William Luther, Namrata Bhatnagar, Yann Jamin, Evon Poon, Takaomi Sanda, Desheng Pei, Bandana Sharma, Winston R Vetharoy, Albert Hallsworth,[...]. Cancer Cell 2012
207
6


Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma.
Sally L George, Federica Lorenzi, David King, Sabine Hartlieb, James Campbell, Helen Pemberton, Umut H Toprak, Karen Barker, Jennifer Tall, Barbara Martins da Costa,[...]. EBioMedicine 2020
18
33

Enrichment of Targetable Mutations in the Relapsed Neuroblastoma Genome.
Olivia M Padovan-Merhar, Pichai Raman, Irina Ostrovnaya, Karthik Kalletla, Kaitlyn R Rubnitz, Eric M Sanford, Siraj M Ali, Vincent A Miller, Yael P Mossé, Meaghan P Granger,[...]. PLoS Genet 2016
62
9


Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.
Richard P Koche, Elias Rodriguez-Fos, Konstantin Helmsauer, Martin Burkert, Ian C MacArthur, Jesper Maag, Rocio Chamorro, Natalia Munoz-Perez, Montserrat Puiggròs, Heathcliff Dorado Garcia,[...]. Nat Genet 2020
81
7

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma.
Mathieu Chicard, Leo Colmet-Daage, Nathalie Clement, Adrien Danzon, Mylène Bohec, Virginie Bernard, Sylvain Baulande, Angela Bellini, Paul Deveau, Gaëlle Pierron,[...]. Clin Cancer Res 2018
80
6

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.
Julie R Park, Rochelle Bagatell, Susan L Cohn, Andrew D Pearson, Judith G Villablanca, Frank Berthold, Susan Burchill, Ariane Boubaker, Kieran McHugh, Jed G Nuchtern,[...]. J Clin Oncol 2017
134
5

Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.
M Schwab, K Alitalo, K H Klempnauer, H E Varmus, J M Bishop, F Gilbert, G Brodeur, M Goldstein, J Trent. Nature 1983
5

Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers.
Satoru Kyo, Masahiro Takakura, Toshiyoshi Fujiwara, Masaki Inoue. Cancer Sci 2008
255
5

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors.
Yuchen Jiao, Chanjuan Shi, Barish H Edil, Roeland F de Wilde, David S Klimstra, Anirban Maitra, Richard D Schulick, Laura H Tang, Christopher L Wolfgang, Michael A Choti,[...]. Science 2011
5

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes.
Christopher M Heaphy, Andrea P Subhawong, Seung-Mo Hong, Michael G Goggins, Elizabeth A Montgomery, Edward Gabrielson, George J Netto, Jonathan I Epstein, Tamara L Lotan, William H Westra,[...]. Am J Pathol 2011
313
5

Clinical features of ATRX or DAXX mutated neuroblastoma.
Sho Kurihara, Eiso Hiyama, Yoshiyuki Onitake, Emi Yamaoka, Keiko Hiyama. J Pediatr Surg 2014
29
17

Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
W B London, R P Castleberry, K K Matthay, A T Look, R C Seeger, H Shimada, P Thorner, G Brodeur, J M Maris, C P Reynolds,[...]. J Clin Oncol 2005
328
5

Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project.
G Schleiermacher, V Mosseri, W B London, J M Maris, G M Brodeur, E Attiyeh, M Haber, J Khan, A Nakagawara, F Speleman,[...]. Br J Cancer 2012
105
5

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.
Zhenghao Li, Hisanori Takenobu, Amallia Nuggetsiana Setyawati, Nobuhiro Akita, Masayuki Haruta, Shunpei Satoh, Yoshitaka Shinno, Koji Chikaraishi, Kyosuke Mukae, Jesmin Akter,[...]. Oncogene 2018
38
13

Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma.
Sharon J Diskin, Mario Capasso, Robert W Schnepp, Kristina A Cole, Edward F Attiyeh, Cuiping Hou, Maura Diamond, Erica L Carpenter, Cynthia Winter, Hanna Lee,[...]. Nat Genet 2012
190
5

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
5


Correlating telomerase activity levels with human neuroblastoma outcomes.
E Hiyama, K Hiyama, T Yokoyama, Y Matsuura, M A Piatyszek, J W Shay. Nat Med 1995
593
5

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger, Staffan Nilsson, Jonas Abrahamsson, Per Kogner, Tommy Martinsson. Proc Natl Acad Sci U S A 2010
145
5

Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979-2015.
Frank Berthold, Claudia Spix, Peter Kaatsch, Fritz Lampert. Paediatr Drugs 2017
46
10

The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Jeyran Shahbazi, Pei Y Liu, Bernard Atmadibrata, James E Bradner, Glenn M Marshall, Richard B Lock, Tao Liu. Clin Cancer Res 2016
81
6

Mechanisms of neuroblastoma regression.
Garrett M Brodeur, Rochelle Bagatell. Nat Rev Clin Oncol 2014
162
5

Drugging MYCN through an allosteric transition in Aurora kinase A.
William Clay Gustafson, Justin Gabriel Meyerowitz, Erin A Nekritz, Justin Chen, Cyril Benes, Elise Charron, Erin F Simonds, Robert Seeger, Katherine K Matthay, Nicholas T Hertz,[...]. Cancer Cell 2014
169
5

Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres.
Peter W Lewis, Simon J Elsaesser, Kyung-Min Noh, Sonja C Stadler, C David Allis. Proc Natl Acad Sci U S A 2010
525
5

ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.
Zulekha A Qadeer, David Valle-Garcia, Dan Hasson, Zhen Sun, April Cook, Christie Nguyen, Aroa Soriano, Anqi Ma, Lyra M Griffiths, Maged Zeineldin,[...]. Cancer Cell 2019
29
17

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.
Bieke Decaesteker, Geertrui Denecker, Christophe Van Neste, Emmy M Dolman, Wouter Van Loocke, Moritz Gartlgruber, Carolina Nunes, Fanny De Vloed, Pauline Depuydt, Karen Verboom,[...]. Nat Commun 2018
41
12

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.
Esther Rheinbay, Morten Muhlig Nielsen, Federico Abascal, Jeremiah A Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj, Julian M Hess, Randi Istrup Juul, Ziao Lin,[...]. Nature 2020
205
5

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
610
5

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
5

DNA damage foci at dysfunctional telomeres.
Hiroyuki Takai, Agata Smogorzewska, Titia de Lange. Curr Biol 2003
5

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma.
Jane Carr-Wilkinson, Kieran O'Toole, Katrina M Wood, Christine C Challen, Angela G Baker, Julian R Board, Laura Evans, Michael Cole, Nai-Kong V Cheung, Joachim Boos,[...]. Clin Cancer Res 2010
113
5

Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway.
Courtney A Lovejoy, Wendi Li, Steven Reisenweber, Supawat Thongthip, Joanne Bruno, Titia de Lange, Saurav De, John H J Petrini, Patricia A Sung, Maria Jasin,[...]. PLoS Genet 2012
372
5

Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.
L L Wang, R Teshiba, N Ikegaki, X X Tang, A Naranjo, W B London, M D Hogarty, J M Gastier-Foster, A T Look, J R Park,[...]. Br J Cancer 2015
76
6

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma.
Rui Dong, Ran Yang, Yong Zhan, Hua-Dong Lai, Chun-Jing Ye, Xiao-Ying Yao, Wen-Qin Luo, Xiao-Mu Cheng, Ju-Ju Miao, Jun-Feng Wang,[...]. Cancer Cell 2020
47
10

Telomere biology including TERT rearrangements in neuroblastoma: a useful indicator for surgical treatments.
Masumi Kawashima, Masato Kojima, Yuka Ueda, Sho Kurihara, Eiso Hiyama. J Pediatr Surg 2016
15
33

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Scott C Bresler, Daniel A Weiser, Peter J Huwe, Jin H Park, Kateryna Krytska, Hannah Ryles, Marci Laudenslager, Eric F Rappaport, Andrew C Wood, Patrick W McGrady,[...]. Cancer Cell 2014
215
5

ARID1A loss in neuroblastoma promotes the adrenergic-to-mesenchymal transition by regulating enhancer-mediated gene expression.
Hui Shi, Ting Tao, Brian J Abraham, Adam D Durbin, Mark W Zimmerman, Cigall Kadoch, A Thomas Look. Sci Adv 2020
22
22

Clinical and biologic features predictive of survival after relapse of neuroblastoma: a report from the International Neuroblastoma Risk Group project.
Wendy B London, Victoria Castel, Tom Monclair, Peter F Ambros, Andrew D J Pearson, Susan L Cohn, Frank Berthold, Akira Nakagawara, Ruth L Ladenstein, Tomoko Iehara,[...]. J Clin Oncol 2011
182
5


ALTernative Telomere Maintenance and Cancer.
Robert L Dilley, Roger A Greenberg. Trends Cancer 2015
128
5

Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma.
Selina Jansky, Ashwini Kumar Sharma, Verena Körber, Andrés Quintero, Umut H Toprak, Elisa M Wecht, Moritz Gartlgruber, Alessandro Greco, Elad Chomsky, Thomas G P Grünewald,[...]. Nat Genet 2021
31
16

Targeting anaplastic lymphoma kinase in neuroblastoma.
Ganesh Umapathy, Patricia Mendoza-Garcia, Bengt Hallberg, Ruth H Palmer. APMIS 2019
27
18

Neuroblastoma: clinical and biological approach to risk stratification and treatment.
Vanessa P Tolbert, Katherine K Matthay. Cell Tissue Res 2018
85
5

Detection of tumor ALK status in neuroblastoma patients using peripheral blood.
Valérie Combaret, Isabelle Iacono, Angela Bellini, Stéphanie Bréjon, Virginie Bernard, Aurélien Marabelle, Carole Coze, Gaelle Pierron, Eve Lapouble, Gudrun Schleiermacher,[...]. Cancer Med 2015
53
9

Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours.
David T W Jones, Ana Banito, Thomas G P Grünewald, Michelle Haber, Natalie Jäger, Marcel Kool, Till Milde, Jan J Molenaar, Arash Nabbi, Trevor J Pugh,[...]. Nat Rev Cancer 2019
56
8

The landscape of genomic alterations across childhood cancers.
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, Ivo Buchhalter, Kortine Kleinheinz, Vasilisa A Rudneva, Pascal D Johann, Gnana Prakash Balasubramanian, Maia Segura-Wang, Sebastian Brabetz,[...]. Nature 2018
580
5

Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.
André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh,[...]. Clin Cancer Res 2015
53
9

Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma.
Konstantin Helmsauer, Maria E Valieva, Salaheddine Ali, Rocío Chamorro González, Robert Schöpflin, Claudia Röefzaad, Yi Bei, Heathcliff Dorado Garcia, Elias Rodriguez-Fos, Montserrat Puiggròs,[...]. Nat Commun 2020
44
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.